Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

Cognitive and Behavioral Practice

Volumn 12, Issue 2, 2005, Pages 252-262

  Ginsburg, Golda S ^a   Albano, Anne Marie ^b   Findling, Robert L ^c   Kratochvil, Christopher ^d   Walkup, John ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DECISION MAKING; DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION PROCESSING; MENTAL HEALTH CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; TREATMENT PLANNING;

EID: 32444436277     PISSN: 10777229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1077-7229(05)80030-6     Document Type: Article

References (49)

1. American Academy of Child and Adolescent Psychiatry. (1998). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37(Suppl. 10), 63S-83S.
2. Biederman, J., Mick, E., & Faraone, S. V. (1998). Depression in attention deficit hyperactivity disorder (ADHD) children: "True" depression or demoralization? Journal of Affective Disorders, 47, 113-122.
3. Birmaher, B., Brent, D. A., & Benson, R. S. (1998). Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 1234-1238.
4. Calabrese, J. R., Shelton, M., Bowden, C. L., Rapport, D. J., Suppes, T, Shirley, E. R., Kimmel, S. E., & Caban, S. J. (2001). Bipolar rapid cycling: Focus on depression as its hallmark. Journal of Clinical Psychiatry, 62(Suppl. 14), 34-41.
5. Cornelius, J. R., Salloum, I. M., Ehler, J. G. Jarrett, P. J., Cornelius, M. D., Perel J. M., Thase, M. E., & Black, A. (1997). Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Archives of General Psychiatry, 54, 700-705.
6. Curry, J. (2001). Specific psychotherapies for childhood and adolescent depression, Biological Psychiatry, 49, 1091-1100.
7. Emslie, G. J., Findling, R. L., Rynn, M. A., Marcus, R. N., Fernandes, L. A., D'Amico, M. F., & Hardy, S. A. (2002). Efficacy and safety of nefaxodone in the treatment of adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 12, 299.
8. Emslie, G. J., Heiligenstein, J. H., Hoog, S. L., Findling, R. L., Wagner, K. D., Ernest, D. E., Van Hoy, B., Sundell, K., Nilsson, M., Babcock, S., & Jacobson, J. G. (2001). Fluoxetine for maintenance of recovery from depression in children and adolescents: A placebo controlled, randomized clinical trial. Journal of Child and Adolescent Psychopharmacology, 11, 328-329.
9. Emslie, G. J., Heiligenstein, J. H., & Wagner, K. D. (2002). Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 1205-1215.
10. Emslie, G. J., Heiligenstein, J. H., Wagner, K. D., Hoog, S. L., Ernest, D. E., Brown, E., Nilsson, M., & Jacobson, J. G. (2002). Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205-1215.
11. Emslie, G. J., Rush, A. J., Weinberg, W. A., Gullion, C. M., Rintelmann, J., & Hughes, C. W. (1997). Recurrence of major depressive disorder in hospitalized children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 785-792.
12. Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., et al. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Pychiatry, 54, 1031-1037.
13. Essau, C., & Dobson, K. (1999). Epidemiology of depressive disorders. In C. Essau & F. Petermann (Eds.), Depressive of Disorders in Children find Adolescents: Epidemiology, Course and Treatment (pp. 69-103). Northvale, NJ: Jason Aronson.
14. Findling, R. L., Feeny, N. C., Stansbrey, R. J., Delporto-Bedoya, D., & Demeter, C. (2002). Somatic treatment for depressive illnesses in children and adolescents. Child and Adolescent Psychiatric Clinics of North America, 11, 555-578.
15. Findling, R. L., Gracious, B. L., McNamara, N. K., Youngstrom, E. A., Demeter, C. A., Branicky, L. A., & Calabrese, J. R. (2001). Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar 1 disorder. Bipolar Disorders, 3, 202-210.
16. Findling, R. L., Kowatch, R. A., & Post, R. M. (2002). Pediatric Bipolar Disorder. A handbook for clinicians. London: Martin Dimitz.
17. Findling, R. L., McNamara, N. K., Gracious, B. L., Youngstrom, E. A., Stansbrey, R. J., Reed, M. D., Demeter, C. A., Branicky, L. A., Fisher, K. E., & Calabrese, J. R. (2003). Combination lithium and divalproex sodium in pediatric bipolarity. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 895-901
18. Findling, R. L., McNamara, N. K., O'Riordan, M. A., Reed, M. D., Demeter, C. A., Branicky, L. A., Blumer, J. L. (2003). An openlabel pilot study of St. John's wort in juvenile depression. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 908-914
19. Geller, B., Fox, L. W., & Clark, K. A. (1994). Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 461-468.
20. Harrington, R., Whittaker, J., Shoebridge, P., & Campbell, F. (1998). Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. British Medical Journal, 316, 1559-1563.
21. Hollon, S. D., Garber, J., & Shelton, R. C. (2005). Treatment of depression in adolescents with cognitive behavior therapy and medications: A commentary on the TADS project. Cognitive and Behavioral Practice, 12, 149-155.
22. Hoog, S. L., Heiligenstein, J. H., Wagner, K. D., Findling, R. L., Ernest, D. E., Nilsson, M., & Jacobson, J. G. (2001). Fluoxetine treatment 20 mg versus 40-60 mg for pediatric fluoxetline 20 mg nonresponders [Abstract]. American Psychiatric Association Annual Meeting New Research Abstracts.
23. Hutto, B. (1998). Subtle psychiatric presentations of endocrine diseases. Psychiatric. Clinics of North America, 21, 905-916.
24. Kashani, J. H., Beck, N. C., Hoeper, E. W., Fallahi, C., Corcoran, C. M., McAllister, J. A., Rosenberg, T. K., & Reid, J. C. (1987). Psychiatric disorders in a community sample of adolescents. American Journal of Psychiatry, 144, 584-589.
25. Kashani, J. H., Carlson, G. A., Beck, N. C., Hoeper, E. W., Corcoran, C. M., McAllister, J. A., et al. (1987). Depression, depressive symptoms, and depressed mood among a community sample of adolescents. American Journal of Psychiatry, 144, 931-934.
26. Kaslow, N., & Thompson, M. (1998). Applying the criteria for empirically supported treatments to studies of psychosocial interventions for child and adolescent depression. Journal of Clinical Child Psychology, 27, 146-155.
27. Keller, M. B., Ryan, N. D., Strober, M., Klein, R. G., Kutcher, S. P., Birmaher, B., Hagino, O. R., Koplewicz, H., Carlson, G. A., Clarke, G. N., Emslie, G. J., Feinberg, D., Geller, B., Kusumakar, V., Papatheodorou, G., Sack, W.H., Sweeney, M., Wagner, K. D., Weller, E. B., Winters, N. C., Oakes, R., & McCafferty, J. P. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 762-772.
28. Kennard, B. D., Ginsburg, G. S., Feeny, N. C., Sweeney, M., & Zagurski, R. (2005). Implementation challenges to TADS cognitive-behavioral therapy. Cognitive and the behavioral Practice, 12, 230-239.
29. Kowatch, R. A., Sethuraman, G., Hume, J. H., Kromelis, M., & Weinberg, W. A. (2003). Combination pharmacotherapy in children and adolescents with bipolar disorder. Biological Psychiatry, 53, 978-984.
30. Kraepelin, E. (1921). Manic-depressive insanity and paranoia, Robertson GM ed. Edinburgh: E & S Livingstone
31. Lewinsohn, P. M., & Clarke G. N. (1999). Psychosocial treatments for adolescent depression. Clinical Psychology Review, 19, 329-342.
32. Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley, J. R., & Andrews, J. A. (1993). Adolescent psychopathology: 1. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology, 102, 133-144.
33. March, J., & Wells, K. (2003). Combining medication and psychotherapy. In A. Martin, L. Scahill, D. S. Charney, & J. F. Leckman (Eds.), Pediatric Psychopharmacology: Principles and Practice, (pp. 426-446). London: Oxford University Press.
34. McGuffin, P., Rijsdijk, F., Andrew, M., Sham, P., Katz, R., & Cardno, A. (2003). The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Archives of Central Psychiatry, 60, 497-502.
35. Medicines and Healthcare Products Regulatory Agency. (2003). Safety of Seroxat (paroxetine) in children and adolescents under 18 years: Contraindication in the treatment of depressive illness. Retrieved March 25, 2005, from http://medicines.mhra.gov.uk/ ourwork/monitorsafeqtialmed/ safetymessages/seroxat18.pdf
36. Papolos, D. F. (2003). Switching, cycling, and antidepressant-indtieed effects on cycle frequency and course of illness in adult bipolar disorder: a brief review and commentary. Journal of Child and Adolescent Psychopharmacology, 13, 165-171.
37. Pies, R. W. (1994). Medical "mimics" of depression. Psychiatric. Annals, 24, 519-520
38. Reinecke, M. A., Ryan, N. E., & DuBois, D. L. (1998). Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: A review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 26-34.
39. Rogers, G. M., Reinecke, M. A., & Curry, J. F. (2005). Case formulation in TADS CBT. Cognitive, and Behavioral Practice, 12, 198-208.
40. Strober, M., Lampert, C., Schmidt, S., & Morrell, W. (1993). The course of major depressive disorder in adolescents: 1. Recovery and risk of manic switching in a follow-up of psychotic and non-psychotic subtypes. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 34-42.
41. Treatment for Adolescents With Depression Study Team. (2003). Treatment for adolescents with depression study (TADS): Rationale, design, and methods. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 531-542.
42. Treatment for Adolescents with Depression Study Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807-820.
43. U.S. Food and Drug Administration. (2003a). FDA approves Prozac for pediatric use to treat depression and OCD. Retrieved March 25, 2005, from http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01187. html
44. U.S. Food and Drug Administration. (2003b). FDA statement regarding the anti-depressant Paxil for pediatric population. Retrieved March 25, 2005, from http://www.fda.gov/bbs/topics/ANSWERS/2003/ ANS01230.html
45. U.S. Food and Drug Administration. (2003c). Reports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD). Retrieved March 25, 2005, from http:// www.fda.gov/cder/drug/advisory/mdd.htm
46. Wagner, K. D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M.S., Childress, A., Donnelly, C., Deas, D., for the Sertraline Pediatric Depression Study Group. (2003). Efficacy of sertralinein the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. Journal of the American Medical Association, 290, 1033-1041.
47. Wagner, K. D., Robb, A. S., Findling, R., & Tiseo, P. (2002). Citalopram is effective in the treatment of major depressive disorder in children and adolescents: Results of a placebo-controlled trial. International Journal of Neuropsychopharmacology, 5(Suppl. 1), S 161.
48. Wells, K. C., & Albano, A. M. (2005). Parent involvement in CBT treatment of adolescent depression: Experiences in the Treatment for Adolescents With Depression Study (TADS). Cognitive and Behavioral Practice, 12, 209-220.
49. Wisner, K. L., Zarin, D. A., Homboe, E. S., Appelbaum, P. S., Gelenberg, A. J., Leonard, H. L., & Frank, E. (2000). Risk-benefit decision making for treatment of depression during pregnancy. American Journal of Psychiatry, 157, 1933-1940.